MEX3A is known to be upregulated in Wilms renal cancer (Krepischi et al., 2016), gastric cancer (Jiang et al., 2012), bladder cancer (Huang et al., 2017) and bladder urothelial cancer (Shi & Huang, 2017). Here, MEX3A is linked to urinary bladder carcinoma.